-
Boeing reports narrowing loss, points to progress on turnaround
-
Oil up, stocks mixed on uncertain prospects for US-Iran ceasefire
-
Germany halves 2026 growth forecast on Iran war fallout
-
Chinese EVs look to sideline foreign brands at Beijing auto show
-
Russia to block flow of Kazakh oil to German refinery, Berlin says
-
Vietnam, South Korea sign deals on tech, nuclear power
-
EU nears approval of Ukraine loan after Hungary pipeline row
-
Duterte jurisdiction appeal quashed at ICC
-
Three ships targeted in Hormuz, Iran seizes two: monitors, Guards
-
Iran says seized two ships seeking to cross Strait of Hormuz
-
Iran murals project defiance in war with US
-
Oil prices rise despite US-Iran ceasefire extension
-
Ships attacked in Gulf as Trump extends Iran ceasefire
-
Germany set to slash growth forecast due to Mideast war
-
Pakistan's capital holds its breath with US-Iran talks in limbo
-
Groundbreaking Iranian snooker star Vafaei takes on the world
-
Sakib Hussain: IPL quick whose mum sold her jewellery to fund cricket dream
-
US-based Buddhist monks bring peace walk to Sri Lanka
-
NASA unveils new space telescope to give 'atlas of the universe'
-
Trump extends ceasefire, claims Iran 'collapsing financially'
-
The tiny, defiant Nile island caught in the heart of Sudan's war
-
UK inflation jumps as Mideast war propels energy prices
-
Oil falls, stocks mixed as traders weigh outlook after Trump extends truce
-
Oil, stocks mixed as traders weigh outlook after Trump extends truce
-
Anthropic probes unauthorized access to Mythos AI model
-
Stadium that was symbol of NZ post-quake rebuild to hold first match
-
Blazers stun Spurs after Wemby injury, Lakers down Rockets
-
Chinese carmakers aim to build up presence in Europe
-
Maoist landmine legacy haunts India
-
Fiji villagers reject plan for 'Pacific ashtray' in beach paradise
-
India orders school water bells to beat heat
-
Japanese minnows one win from fairytale Champions League title
-
Rugby Australia eyes brighter future as Lions tour brings cash windfall
-
Blazers rally stuns Spurs after Wembanyama injury
-
Young Chinese use AI to launch one-person firms over job anxiety
-
Delicate extraction: Malaysia offers rare earths alternative to China
-
Oil, stocks fall as traders weigh outlook after Trump extends truce
-
Pope to visit prison on final leg of Africa tour
-
US military says key weapons system staying in South Korea
-
India strangles final Maoist bastion as mining looms
-
AI-powered robots offer new hope to German factories
-
Indonesia orangutan forest cleared for 'carbon-neutral' packaging firm
-
PGA Tour mulls pathway back for golfers as LIV plots survival
-
One month phone-free: Young Americans try digital detox
-
Questions about Tesla spending binge ahead of earnings
-
Rome summons Russian ambassador over insults against Meloni
-
US tells Afghans to choose Taliban home or DR Congo: activist
-
John Ternus to lead Apple in the age of AI
-
SpaceX partners with AI startup Cursor, may buy it for $60 bn
-
Mexico pyramid shooter inspired by Columbine attack, pre-Hispanic sacrifices
Dressing 'revolution' seeks artificial skin for burn victims
Far from the humble sticking plaster, medical firms and researchers are seeking to create the "ultimate dressing" -- artificial skin they hope will revolutionise the treatment of severe burns.
For the last 18 months, researchers from the French firm Urgo have been working towards achieving this Holy Grail of wound treatment, which would save serious burn victims from the painful and repeated skin grafts they currently endure.
The 100-million-euro ($106,000-million) "Genesis" project hopes to have a product ready by 2030.
Guirec Le Lous, the president of Urgo's medical arm, told AFP that it is a "crazy" project.
"Are we capable of designing artificial skin in a laboratory? No one in the world has succeeded," he said.
Inside Urgo's laboratory in Chenove, near the eastern French city of Dijon, living cells are being chilled before they can be cultivated.
"You have to be able to recreate all the functions of skin," including protecting against external threats and regulating the temperature, Le Lous said.
It must also be relatively easy to make, because artificial skin must be "available for all and at the right price," he said, without revealing the exact technology or type of cells Urgo is using.
Urgo, a family-owned business since 1880, has long made dressings for chronic wounds such as diabetic foot ulcers and venous leg ulcers.
"Since the 2000s, we have worked on materials that will correct healing problems: dressings have become intelligent, interactive with wounds, allowing them to perform better," Urgo's research director Laurent Apert said.
He called the change "a revolution".
- Silver bullet -
Urgo is far from alone in pushing the boundaries of what dressings can do.
Researchers at the University of South Australia have developed a new kind of dressing that knows when to release nanoparticles of silver, which can break down antibiotic-resistant bacteria.
"Our treatment is unique in that it capitalises on the anti-bacterial properties of silver, but avoids over-exposure, by only activating when infection in present," lead researcher Zlatko Kopecki said in a statement.
This makes the dressing "a much safer and effective treatment for children," he added.
Children suffer almost half of burn injuries worldwide, most of them aged between one to five years old, according to research using the World Health Organization's Global Burn Registry.
- 'Night and day' -
Another new technique does away with the idea of dressing altogether.
For a product from French startup VistaCare Medical, patients put their affected leg into a large device which never touches their wound.
Instead the chamber controls the humidity, temperature and other aspects important to healing.
"There is no more dressing. The idea is to put the wound in an enclosure, in a sterile air, VistaCare Medical president Francois Dufay said.
"With this system, we provide the wound with what it needs, at the right time."
VistaCare Medical's device is currently used in around 20 French hospitals, but next year the firm plans to apply for approval in the United States for a product to be used in the home.
The new developments have shaken up the world of wound healing, long a neglected area of medical research.
Isabelle Fromantin, who heads the wounds and healing research unit at the Curie Institute in Paris, said that "compared to 20 years ago, it's night and day in terms of wound care".
Along with her team, Fromantin has developed dressings that reduce the odours from necrotic wounds seen in some cancers.
However she said that not everything can be achieved by new technologies -- healing is a process that varies from person to person, depending on their age and health.
"Believing that a dressing will heal you all by itself is utopian," she said.
I.Yassin--SF-PST